3. How comprehensive can we be in the economic assessment of vaccines?

In two previous papers we argued on current vaccines economic assessment not fully comprehensive when using the incremental cost-utility analysis normally applied for treatments. Many differences exist between vaccines and drug treatments making vaccines economic evaluation more cumbersome. Four cha...

Descripción completa

Detalles Bibliográficos
Autores principales: Standaert, Baudouin, Rappuoli, Rino
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Routledge 2017
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5956290/
https://www.ncbi.nlm.nih.gov/pubmed/29785253
http://dx.doi.org/10.1080/20016689.2017.1336044

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5956290/
https://www.ncbi.nlm.nih.gov/pubmed/29785253
http://dx.doi.org/10.1080/20016689.2017.1336044

Ejemplares similares